Aandeel A015540 THELMA THERAPEUTICS CO., LTD.
Toevoegen aan een lijst
Om deze functie te gebruiken moet u een klant of lid zijn.
InloggenRegistreren
Inactief instrument

Andere talen THELMA Therapeutics Co., Ltd.

Aandelen

A015540

KR7015540008

Andere talen

Zoeken op
Resultaten bekijken
Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!
Gratis inschrijven
THELMA Therapeutics Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
THELMA Therapeutics Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
THELMA Therapeutics Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
THELMA Therapeutics Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
THELMA Therapeutics Co., Ltd. announced that it has received KRW 4.779985 billion in funding from AirQ Holdings Inc.
THELMA Therapeutics Co., Ltd. announced that it has received KRW 10.220014 billion in funding from AirQ Holdings Inc. and other investors.
THELMA Therapeutics Co., Ltd. cancelled the transaction announced on December 16, 2021
Tranche Update on THELMA Therapeutics Co., Ltd.'s Equity Buyback Plan announced on January 5, 2023.
THELMA Therapeutics Co., Ltd.'s Equity Buyback announced on January 5, 2023, has closed with 195,868 shares.
THELMA Therapeutics Co., Ltd. announces an Equity Buyback for 195,868 shares.
THELMA Therapeutics Co., Ltd. authorizes a Buyback Plan.
THELMA Therapeutics Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
Thelma Therapeutics to Raise $7.3 Million via Stock Offering
THELMA Therapeutics Co., Ltd. announced that it expects to receive KRW 9.9999998 billion in funding from AirQ Holdings Inc.
THELMA Therapeutics Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
THELMA Therapeutics Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
THELMA Therapeutics Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
THELMA Therapeutics Co., Ltd. announced that it expects to receive KRW 4.9999999 billion in funding from AirQ Holdings Inc.
THELMA Therapeutics Co., Ltd. announced that it expects to receive KRW 4.9999999 billion in funding
THELMA Therapeutics Co., Ltd. announced that it has received KRW 2.8 billion in funding
Geen resultaten voor deze zoekopdracht
Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

Zoeken op

Datum van publicatie

Sinds de

Tot

  1. Beurs
  2. Aandelen
  3. Koers A015540
  4. Nieuws THELMA Therapeutics Co., Ltd.
  5. Andere talen